dr. schenkein on ag-221 for the treatment of aml
Published 10 years ago • 812 plays • Length 1:04Download video MP4
Download video MP3
Similar videos
-
0:56
dr. eytan stein discusses the idh2 inhibitor ag-221 in aml
-
7:18
phase i study shows ag-221 induces durable remissions in idh2-mutant acute myeloid leukaemia
-
0:58
dr. powell on the treatment of older patients with aml
-
2:38
dr. erba on flt3 inhibitors for the treatment of aml
-
1:25
dr. gail roboz on improving the standard treatment of aml
-
48:11
sglt-2 inhibitoren nach myokardinfarkt - emmy - prof. h. sourij und prof. d. von lewinski (graz)
-
1:51
phase ii extension trial of cnm-au8 in als
-
2:19
acute myeloid leukemia - causes, symptoms, treatments & more…
-
1:42
dr. faderl gives an overview of novel therapies for aml
-
1:22
dr. flynn on cdk inhibitors for the treatment of cll
-
6:05
implications for treating aml with cc-486
-
0:43
dr. faderl discusses combining chemotherapy and flt3 inhibitors in aml
-
1:30
dr. erba on treatment-related mortality rates in aml
-
1:02:16
10000000 1121876064991107 4170721846864732925 n
-
1:24
dr. erba on curative therapy for aml
-
1:20
dr. powell on cpi-613, cytarabine, mitoxantrone combo for aml
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
1:36
impact of the revised eln-2017 aml recommendations
-
2:11
selecting aml patients for intensive treatment
-
1:24
exciting immunotherapy clinical trials for the management of aml
-
4:08
cc-486 maintenance therapy in aml